AiViva Biopharma, Inc.
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2016-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.aiviva.com
Clinical Trials
6
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials
Effect of AIV007 by Periocular Administration in Subjects with Macular Edema Secondary to Neovascular Age-related Macular Degeneration (nAMD) and Diabetic Macular Edema (DME)
- Conditions
- Neovascular Age-related Macular DegenerationDiabetic Macular EdemaMacular Edema
- Interventions
- First Posted Date
- 2023-01-26
- Last Posted Date
- 2025-03-06
- Lead Sponsor
- AiViva BioPharma, Inc.
- Target Recruit Count
- 19
- Registration Number
- NCT05698329
- Locations
- 🇺🇸
Retina-Vitreous Associates, Beverly Hills, California, United States
🇺🇸Orange County Retina, Santa Ana, California, United States
🇺🇸Verum Research, Eugene, Oregon, United States
Safety and Efficacy of AIV001 on Scar Formation and Keloid Recurrence Following Keloidectomy
- First Posted Date
- 2021-04-01
- Last Posted Date
- 2024-12-27
- Lead Sponsor
- AiViva BioPharma, Inc.
- Target Recruit Count
- 25
- Registration Number
- NCT04827875
- Locations
- 🇺🇸
Skin Research Institute, Coral Gables, Florida, United States
🇺🇸DermResearch DRI, Austin, Texas, United States
🇺🇸J&S Studies, College Station, Texas, United States
Safety and Efficacy Evaluation of AIV001 in Nonmelanoma Skin Cancer of the Low Risk Basal Cell Carcinoma Subtype
- Conditions
- Superficial Basal Cell CarcinomaNodular Basal Cell CarcinomaNonmelanoma Skin Cancers
- Interventions
- Drug: AIV001 suspension
- First Posted Date
- 2020-07-14
- Last Posted Date
- 2025-03-25
- Lead Sponsor
- AiViva BioPharma, Inc.
- Target Recruit Count
- 26
- Registration Number
- NCT04470726
- Locations
- 🇺🇸
Skin Surgery Medical Group, San Diego, California, United States
🇺🇸California Dermatology & Clinical Research Institute, Encinitas, California, United States
🇺🇸Island Dermatology, Newport Beach, California, United States
Effect of Intravitreally Administered AIV007 in Subjects With Neovascular Age-Related Macular Degeneration
- First Posted Date
- 2020-06-09
- Last Posted Date
- 2024-12-27
- Lead Sponsor
- AiViva BioPharma, Inc.
- Target Recruit Count
- 3
- Registration Number
- NCT04422899
- Locations
- 🇺🇸
Salehi Retina Institute, Huntington Beach, California, United States
🇺🇸Retina Research Institute of Texas, Abilene, Texas, United States
A Safety and Efficacy Study to Evaluate Rosacea
- First Posted Date
- 2019-03-21
- Last Posted Date
- 2024-12-17
- Lead Sponsor
- AiViva BioPharma, Inc.
- Registration Number
- NCT03883945
- Locations
- 🇺🇸
Cosmetic Laser Dermatology, San Diego, California, United States
- Prev
- 1
- 2
- Next